EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Durability of immune responses to mRNA booster vaccination against COVID-19

Prabhu S Arunachalam, Lilin Lai, Hady Samaha, Yupeng Feng, Mengyun Hu, Harold Sai-Yin Hui, Bushra Wali, Madison Ellis, Meredith E Davis-Gardner, Christopher Huerta, Kareem Bechnak, Sarah Bechnak und 9 weitere

Journal of Clinical Investigation · 15.05.2023 · 133 (10)

DOI: 10.1172/jci167955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.05.2023. Verfasst von Prabhu S Arunachalam und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AdultHumansSARS-CoV-2COVID-19 VaccinesVaccinationRNA, MessengerImmunityAntibodies, ViralAntibodies, Neutralizing

Stichwörter der Autor:innen

Adaptive immunityVaccines

Substanzen

COVID-19 VaccinesRNA, MessengerAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford University, Stanford, California, USA.
  • Department of Pediatrics, Emory Vaccine Center, Emory National Primate Research Center, Atlanta, Georgia, USA.
  • Hope Clinic of the Emory Vaccine Center, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Decatur, Georgia, USA.
  • Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, California, USA.
  • Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS

Zitieren

APA

Arunachalam, P. S., Lai, L., Samaha, H., Feng, Y., Hu, M., Hui, H. S., Wali, B., Ellis, M., Davis-Gardner, M. E., Huerta, C., Bechnak, K., Bechnak, S., Lee, M., Litvack, M. B., Losada, C., Grifoni, A., Sette, A., Zarnitsyna, V. I., Rouphael, N., …, & Pulendran, B. (2023). Durability of immune responses to mRNA booster vaccination against COVID-19. Journal of Clinical Investigation, 133(10). https://doi.org/10.1172/jci167955

Vancouver

Arunachalam PS, Lai L, Samaha H, Feng Y, Hu M, Hui HS, et al. Durability of immune responses to mRNA booster vaccination against COVID-19. Journal of Clinical Investigation. 2023;133(10). doi:10.1172/jci167955

BibTeX
@article{Arunachalam2023,
  author = {Arunachalam, Prabhu S and Lai, Lilin and Samaha, Hady and Feng, Yupeng and Hu, Mengyun and Hui, Harold Sai-Yin and Wali, Bushra and Ellis, Madison and Davis-Gardner, Meredith E and Huerta, Christopher and Bechnak, Kareem and Bechnak, Sarah and Lee, Matthew and Litvack, Matthew B and Losada, Cecilia and Grifoni, Alba and Sette, Alessandro and Zarnitsyna, Veronika I and Rouphael, Nadine and Suthar, Mehul S and Pulendran, Bali},
  title = {Durability of immune responses to mRNA booster vaccination against COVID-19},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {10},
  doi = {10.1172/jci167955}
}
Kostenlos starten →